Chemoinformaics analysis of [(2R)-3-ACETYLOXY-2-HYDROXYPROPYL] 2-AMINOETHYL PHOSPHATE
| Molecular Weight | 256.171 | nRot | 8 |
| Heavy Atom Molecular Weight | 241.051 | nRig | 10 |
| Exact Molecular Weight | 256.059 | nRing | 0 |
| Solubility: LogS | -1.869 | nHRing | 0 |
| Solubility: LogP | 1.772 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 32.0359 |
| nHD | 2 | BPOL | 30.1301 |
| QED | 0.565 |
| Synth | 2.002 |
| Natural Product Likeliness | 0.339 |
| NR-PPAR-gamma | 0.034 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.004 |
| HIA | 0.008 |
| CACO-2 | -4.489 |
| MDCK | 0.0000129 |
| BBB | 0.43 |
| PPB | 0.794998 |
| VDSS | 0.904 |
| FU | 0.171226 |
| CYP1A2-inh | 0.937 |
| CYP1A2-sub | 0.763 |
| CYP2c19-inh | 0.539 |
| CYP2c19-sub | 0.171 |
| CYP2c9-inh | 0.165 |
| CYP2c9-sub | 0.93 |
| CYP2d6-inh | 0.669 |
| CYP2d6-sub | 0.873 |
| CYP3a4-inh | 0.089 |
| CYP3a4-sub | 0.169 |
| CL | 12.062 |
| T12 | 0.889 |
| hERG | 0.017 |
| Ames | 0.244 |
| ROA | 0.961 |
| SkinSen | 0.902 |
| Carcinogencity | 0.134 |
| EI | 0.993 |
| Respiratory | 0.956 |
| NR-Aromatase | 0.796 |
| Antiviral | No |
| Prediction | 0.809729 |